Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
5.53
-0.53 (-8.75%)
Jul 28, 2026, 4:00 PM EDT - Market closed
Champions Oncology Revenue
In the fiscal year ending April 30, 2026, Champions Oncology had annual revenue of $59.43M with 4.36% growth. Champions Oncology had revenue of $13.84M in the quarter ending April 30, 2026, with 11.98% growth.
Revenue (ttm)
$59.43M
Revenue Growth
+4.36%
P/S Ratio
1.29
Revenue / Employee
$278,991
Employees
213
Market Cap
76.83M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 59.43M | 2.48M | 4.36% |
| Apr 30, 2025 | 56.94M | 6.79M | 13.54% |
| Apr 30, 2024 | 50.16M | -3.72M | -6.90% |
| Apr 30, 2023 | 53.87M | 4.76M | 9.69% |
| Apr 30, 2022 | 49.11M | 8.07M | 19.66% |
| Apr 30, 2021 | 41.04M | 8.92M | 27.76% |
| Apr 30, 2020 | 32.12M | 5.06M | 18.68% |
| Apr 30, 2019 | 27.07M | 6.83M | 33.72% |
| Apr 30, 2018 | 20.24M | 4.83M | 31.34% |
| Apr 30, 2017 | 15.41M | - | - |
| Apr 30, 2016 | - | - | - |
| Apr 30, 2015 | - | - | - |
| Apr 30, 2014 | - | - | - |
| Apr 30, 2013 | - | - | - |
| Apr 30, 2012 | - | - | - |
| Apr 30, 2011 | - | - | - |
| Apr 30, 2010 | - | - | - |
| Apr 30, 2009 | 3.71M | 2.31M | 165.00% |
| Apr 30, 2008 | 1.40M | - | - |
| Apr 30, 2007 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 150.71M |
| Alterity Therapeutics | 4.43M |
| NeurAxis | 4.28M |
| Rallybio | 858.00K |
| Inovio Pharmaceuticals | 65.34K |
| NeOnc Technologies Holdings | 39.99K |
CSBR News
- 1 day ago - Champions Oncology reports Q4 adjusted EPS 1c vs. (8c) last year - TheFly
- 1 day ago - Champions Oncology Earnings Call Transcript: Q4 2026 - Transcripts
- 1 day ago - Champions Oncology Earnings release: Q4 2026 - Filings
- 1 day ago - Champions Oncology Annual report: Q4 2026 - Filings
- 1 day ago - Champions Oncology Reports Record Annual Revenue of $59 Million - Accesswire
- 8 days ago - Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026 - Accesswire
- 3 months ago - Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026 - Accesswire
- 4 months ago - Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy - Accesswire